pharmaceuticals
pharmaceuticals Articles
Portola Pharmaceuticals made waves early on Thursday morning with less than favorable top-line results.
Published:
Last Updated:
Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.
Published:
Last Updated:
Ionis Pharmaceuticals led biotech stocks early on Wednesday following a key patent dispute win in the U.S. court system.
Published:
Last Updated:
Reata Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Akorn reported its preliminary 2015 financial results before the markets opened on Tuesday and issued guidance for the 2016 full year.
Published:
Last Updated:
Celator Pharmaceuticals reported its fourth-quarter financial results before the markets opened on Monday.
Published:
Last Updated:
Advaxis made waves in the markets on Monday following the release of positive data from its most recent study.
Published:
Last Updated:
BioMarin Pharmaceutical made waves early Monday following the release of late-stage results from its pegvaliase study.
Published:
Last Updated:
Releasing preliminary results may have been ill-advised to release, as the impact was absolutely catastrophic to Valeant Pharmaceuticals stock.
Published:
Last Updated:
Over the past week, Celator Pharmaceuticals and a few other biotech companies made impressive runs.
Published:
Last Updated:
Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in ulcerative colitis program at the 11th Congress of European Crohn's and...
Published:
Last Updated:
Eagle Pharmaceuticals shares were in free fall early Friday after it received a Complete Response Letter from the FDA for its Kangio.
Published:
Last Updated:
Vitae Pharmaceuticals watched its shares absolutely take off on Thursday morning following the release of positive results from its mid-stage clinical trial.
Published:
Last Updated:
Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol drug patent.
Published:
Last Updated:
24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.
Published:
Last Updated: